Aarti Industries Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q2 FY26 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 3 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹17.6K Cr

The company expects steady volume growth supported by capacity expansions and debottlenecking initiatives, particularly in MMA, with incremental capacity coming online from Q4 FY26 and through FY27. The company expects medium-term volume visibility to remain healthy across most businesses despite near-term uncertainties (Page 3).

From Aarti Industries Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹527

Market Cap

₹17.6K Cr

P/E Ratio

33.8

How does Aarti Industries Ltd rank in Chemicals & Petrochemicals?

Compare Aarti Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Aarti Industries Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.2K Cr, net profit ₹137 Cr.

Full financials →

📊 Revenue & Sales Performance

→The company expects steady volume growth supported by capacity expansions and debottlenecking initiatives, particularly in MMA, with incremental capacity coming online from Q4 FY26 and through FY27.
→Market expansion efforts continue globally, especially in Europe, Middle East, and Africa, alongside recovery in U.S. volumes as tariff issues are addressed.
→Medium-scale, innovation-led capex projects over the next 2-3 years are aimed at quick turnaround and significant return generation.
→The company anticipates gradual recovery in volumes in agrochemicals and other specialty chemicals segments as trade and margin pressures ease.
→Volume sustainability at current levels is expected to drive operating leverage, supporting margin and revenue growth.
→Long-term volume visibility remains healthy across most businesses despite near-term uncertainties.
→Overall revenue growth is driven by proactive market diversification, increased global footprint, and ongoing capacity additions.

📈 Profitability & Margins

→The company expects medium-term volume visibility to remain healthy across most businesses despite near-term uncertainties (Page 3).
→EBITDA aspirations for FY28 remain a firm commitment, supported by volume ramp-up, cost optimization, and monetization of ongoing capex projects (Page 3).
→Incremental capacity additions such as the multipurpose plant, calcium chloride facility, and PEDA project will drive profitable growth and volume ramp-up in the next 12-18 months (Pages 5, 6).
→Operating leverage is a key driver of margin improvement, expected to support EBITDA growth as volumes increase (Page 6).
→Cost-cutting initiatives totaling INR150-200 crore are underway, with 40-50% of benefits yet to flow through, indicating further profit improvement potential (Page 13).
→Management aims for disciplined capital expenditure focusing on medium-scale projects with fast turnaround and significant returns, avoiding large-ticket capex for the next 2-3 years (Pages 5, 7).
→The balance sheet debt-to-EBITDA ratio may have peaked, with expectations of improvement going forward, supporting financial stability (Page 20).

See what Aarti Industries Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→Ongoing Zone 4 expansion project with new capacities coming online over next few quarters.
→New multipurpose plant (MPP) at Zone 4 to be commissioned in Q4 FY26, enhancing product development flexibility.
→Calcium Chloride facility commissioning expected in the current quarter at Zone 4.
→New 4,000 TPA PEDA project at Zone 4 (Jhagadia) utilizing Ethylation raw materials, targeting agrochemical industry demand.
→Strategic partnership with DCM Shriram for long-term chlorine supply to Zone 4 downstream chemicals facility.
→Debottlenecking initiatives on MMA capacity to scale up volumes further from Q4 FY26.
→Capex for FY26 expected around INR 1,000 crore; FY27 capex to be substantially lower.
→Future capex focus on medium-ticket size projects utilizing existing infrastructure for faster turnaround and returns.
→Emphasis shifting towards innovation-led growth and value-added chemistry as current capex cycle concludes.

💰 Fundraising & Capital Structure

→There is no specific mention of any new fundraising through debt or equity in the transcript.
→The company emphasizes disciplined capital execution with no blockbuster capex planned in the next 2-3 years.
→Future capex will be medium-scale projects focused on quick turnaround and significant returns using existing infrastructure.
→The focus remains on managing the balance sheet prudently, with no indication of immediate or planned large-scale fundraising.
→Debt-to-EBITDA may have already peaked, and the company expects improvement going forward.
→Finance costs may increase modestly due to new projects, but interest rate softening is anticipated to help manage costs.
→Overall, the company aims to maintain a stable debt profile and manage leverage amid ongoing capex and innovation-led growth.

See what Aarti Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

→The transcript does not explicitly mention the current or expected order book or pending orders for Aarti Industries.
→However, management indicated they have active conversations and decent relationships with customers for upcoming projects such as multipurpose plant and PEDA.
→They clarified that none of the upcoming projects have take-or-pay contracts, implying orders are not fully secured with firm commitments.
→Confidence in volume placement exists, supported by ongoing customer engagement.
→The company is commissioning several projects sequentially, suggesting a healthy pipeline but without specific orderbook data disclosed.
→Overall, long-term volume visibility remains healthy across most businesses despite near-term uncertainties.

Key Metrics

How does Aarti Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Aarti Industries Ltd

See full Chemicals & Petrochemicals sector rankings

What AARTIIND's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

IPHL (Q2 FY26)
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…
Alkyl Amines Chemicals Ltd (Q2 FY26)
120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
SUDARSCHEM (Q2 FY26)
The company completed a significant capex investment of roughly INR 700 crores about 3-4 years ago. Key concall takeaways from Sudarshan Chemical Industries…
GNFC (Q2 FY26)
Capex pipeline worth INR 2,800 crores includes expansions in AN melt, weak nitric acid, power and steam plant conversion, and ammonia loop expansion. Key…

Compare:vs Solar Industries India Ltd vs PIDILITIND vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Aarti Industries Ltd Q2 FY26 results?

What is Aarti Industries Ltd share price analysis?

Aarti Industries Ltd currently shows a neutral. The stock trades at a P/E of 33.8 with a market cap of ₹17,627 Cr. Investors should review the full earnings analysis for detailed insights.

Is Aarti Industries Ltd planning capital expenditure?

Ongoing Zone 4 expansion project with new capacities coming online over next few quarters.

Keep Aarti Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.